On February 1, 2024, Fapon, a global leading life science company, and Bio Farma, a state-owned pharmaceutical holding company in Indonesia specializing in vaccines, life science products, and other pharmaceuticals, signed a memorandum of understanding to formalize their commitment to strengthening medical innovations in Indonesia. In doing so, the memorandum will further solidify Fapon's global ecosystem for diagnostics and medical treatment. Jielun ZHU, Chief Financial Officer and Chief Invest
DONGGUAN, China, Feb. 2, 2024 /PRNewswire/ On February 1, 2024, Fapon, a global leading life science company, and Bio Farma, a state-owned pharmaceutical